Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04605081 · ClinicalTrials.gov registry record · Phase 2
Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)
A Phase 2 study of Loss-of-control Eating and Obesity/Overweight, sponsored by Yale University.
- Active
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04605081 is a Phase 2 study of Loss-of-control Eating and Obesity/Overweight that is active but no longer recruiting, run by Yale University. The registered enrollment target is 100 participants, above the 75-participant average among 3 other Loss-of-control Eating trials with a reported enrollment target (33% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04605081, a Phase 2 study of Loss-of-control Eating and Obesity/Overweight, is active but no longer recruiting, sponsored by Yale University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the effectiveness of naltrexone/bupropion medication as a maintenance therapy for the treatment of loss-of-control eating and weight loss following bariatric surgery. This is a controlled test of whether, amongst responders to acute treatments, naltrexone/bupropion medication results in superior maintenance and longer-term outcomes compared with placebo.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Naltrexone and Bupropion (NB) medication
Study Locations (1)
Connecticut
- Yale School of Medicine - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-01-10 |
| Est. Completion | 2027-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04605081
The ClinicalTrials.gov registry entry for NCT04605081 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 75-participant average among 3 other Loss-of-control Eating trials with a reported enrollment target (33% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Loss-of-control Eating appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04605081 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT04605081 about?
NCT04605081 is a clinical study titled "Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)". This study will test the effectiveness of naltrexone/bupropion medication as a maintenance therapy for the treatment of loss-of-control eating and weight loss following bariatric surgery. This is a controlled test of whether, amongst responders to acute treatments, naltrexone/bupropion medication re...
What is the current status of trial NCT04605081?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2022-01-10. Estimated completion is 2027-05.
What conditions does trial NCT04605081 study?
This clinical trial studies the following conditions: Loss-of-control Eating, Obesity/Overweight.
What interventions are being tested in trial NCT04605081?
The interventions under investigation include: Placebo (OTHER), Naltrexone and Bupropion (NB) medication (DRUG).
Who is sponsoring clinical trial NCT04605081?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04605081 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Loss-of-control Eating
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)
RECRUITING · Phase 2
-
Pharmacological and Behavioral Treatment After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)
ACTIVE NOT RECRUITING · Phase 2
-
Responsive Neurostimulation For Loss Of Control Eating
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.